Physician

Nabila Hassan El Zind, M.D.

According to 2025 Medicare claims, Nabila Zind, M.D. (NPI: 1003849035) practices neurology in the Lawton, OK market, with the plurality of this provider's patient population coming from Comanche, OK. Zind uses personal NPI as billing NPI and primary practice location at 73505-5977.

Zind's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 500 traditional Medicare patients, billed 21,998 HCPCS/CPT codes, and received $246,109 in Medicare payments. The top billing code was 95812 (Measurement of brain wave activity (eeg), 41-60 minutes). Part D data shows 8,858 prescription claims across 444 beneficiaries totaling $3,922,629 in drug costs, led by Ingrezza (Valbenazine Tosylate). 2022 DME data shows 26 claims. Open Payments data shows 138 records totaling $2,481. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,748,163 to $3,922,629. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $13,628 and ending at $20,517.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	513	31,200	$324,143
2016	562	22,351	$299,131
2017	604	30,744	$385,822
2018	569	33,014	$362,384
2019	642	37,391	$403,457
2020	575	29,329	$337,857
2021	566	30,317	$368,690
2022	477	26,794	$286,376
2023	446	26,115	$261,152
2024	500	21,998	$246,109

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	345	7,891	$1,748,163
2016	377	8,463	$1,763,899
2017	398	8,460	$1,851,302
2018	367	7,542	$1,822,329
2019	405	8,028	$2,133,933
2020	404	8,450	$2,435,243
2021	386	8,329	$2,071,016
2022	394	8,207	$2,650,537
2023	399	8,460	$3,110,780
2024	444	8,858	$3,922,629

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	146	$8,092
2016	N/R	240	$20,923
2017	N/R	264	$36,448
2018	N/R	323	$38,914
2019	N/R	325	$38,441
2020	N/R	373	$36,570
2021	N/R	240	$12,837
2022	N/R	26	$1,825
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95812	Measurement of brain wave activity (eeg), 41-60 minutes	113	113	$166
95957	Measurement of brain wave activity (eeg), digital analysis	113	113	$153
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	73	76	$114
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	101	101	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	321	762	$71

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ingrezza	Valbenazine Tosylate	51	1,530	$400,936
Austedo Xr	Deutetrabenazine	27	810	$291,983
Vumerity	Diroximel Fumarate	25	750	$230,163
Fintepla	Fenfluramine Hcl	11	330	$208,741
Rebif Rebidose	Interferon Beta-1a/Albumin	12	336	$146,372

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	138	$2,481	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nabila Hassan El Zind, M.D.?

Tedicare shows public-source Medicare data for Nabila Hassan El Zind, M.D. (NPI 1003849035), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nabila Hassan El Zind, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nabila Hassan El Zind, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Nabila Hassan El Zind, M.D. have Open Payments data?

Nabila Hassan El Zind, M.D. has 138 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.